rxstat › Classes › Antipsychotics
Antipsychotics: shortage status in Canada
13 of the 18 antipsychotics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortagePericiazine2 of 4 reported products affectedWidespread shortageTrifluoperazine5 of 5 reported products affectedPartial shortageAripiprazole3 of 29 reported products affected · est. return Jul 17, 2026Partial shortageFluphenazine1 of 2 reported products affected · est. return Jun 5, 2026Partial shortageHaloperidol6 of 16 reported products affected · est. return Jul 10, 2026Partial shortageLithium Carbonate4 of 11 reported products affected · est. return Jan 1, 2027Partial shortageLoxapine4 of 10 reported products affectedPartial shortageLurasidone1 of 19 reported products affected · est. return Jun 19, 2026Partial shortageMethotrimeprazine1 of 4 reported products affected · est. return Jul 17, 2026Partial shortageOlanzapine1 of 106 reported products affected · est. return Aug 7, 2026Partial shortageQuetiapine47 of 117 reported products affected · est. return Dec 31, 2026Partial shortageRisperidone17 of 81 reported products affected · est. return Jul 31, 2026Partial shortageZiprasidone2 of 8 reported products affectedNo current shortageChlorpromazineNo current shortageClozapineNo current shortagePerphenazineDiscontinuedPimozide0 of 2 reported products affectedNo current shortageProchlorperazine
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.